Processa Pharmaceuticals, Inc. Interest Income (Expense), Nonoperating, Net
Processa Pharmaceuticals, Inc. (PCSA) reported Interest Income (Expense), Nonoperating, Net of -$2.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement › Other Income
us-gaap:InterestIncomeExpenseNonoperatingNet · last filed 2026-08-14
- Processa Pharmaceuticals, Inc. interest income (expense), nonoperating, net for the quarter ending 2026-06-30 was -$2.00K, a 122.60% decline year-over-year.
- Processa Pharmaceuticals, Inc. interest income (expense), nonoperating, net for the quarter ending 2025-06-30 was $8.86K.
| Period end | Interest Income (Expense), Nonoperating, Net 3 month | Interest Income (Expense), Nonoperating, Net 6 month |
|---|---|---|
| 2026-06-30 | -$2.00K 10-Q · filed 2026-08-14 | $11.86K 10-Q · filed 2026-08-14 |
| 2025-06-30 | $8.86K 10-Q · filed 2026-08-14 | $21.44K 10-Q · filed 2026-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |